Sanner has officially launched manufacturing operations in Greensboro, North Carolina. The new facility is dedicated to producing critical injection-molded components for medical devices and pharmaceutical packaging, as well as desiccant solutions. This expansion reflects Sanner’s long-term growth strategy and provides customers with a local source for efficient and scalable manufacturing solutions.
Sanner’s new manufacturing facility in Greensboro has started production according to plan. With a total of 60,500 square feet (5,600 square meters), the facility offers capacities for both CDMO and packaging operations. “We’re thrilled to be opening Sanner Group’s first North American injection molding and pharma desiccant packaging facility. Strategically positioned in North Carolina, this site will be supported by our strong design & development and transfer engineering teams already here in Durham and Pittsboro.” says Ted Mosler, President of Sanner US.
Growth opportunities for CDMO services
The GMP-compliant facility with automated environmental monitoring accommodates both white room and Class 7 and 8 cleanroom space, as well as full laboratory capabilities for testing and metrology. With an additional 20,000 square feet (1,800 square meters) of easily expandable production space, Sanner can quickly adapt to growing customer demands. “We are now able to offer our MedTech and Pharma customers the full CDMO service, including injection molding, from a single source in the US.” says Ted Mosler.
Desiccant packaging solutions made in the USA
The new filling room with automated high-speed desiccant filling lines enables Sanner to provide customers in the North American pharmaceutical and nutraceutical industries with packaging solutions made in the USA. Among the first products manufactured in Greensboro are effervescent containers, the premium DASG-1 desiccant closure, and AdCap® desiccant canisters; further products will follow.
Set for further growth
Sanner recently acquired the Durham-based CDMO, Gilero, a firm specializing in medical design, development, manufacturing, assembly, and packaging. Sanner also opened its second production facility in Kunshan, China, in 2023 and started production at the new state-of-the-art manufacturing site and headquarters in Bensheim, Germany, this year.
“The opening of our new facility in Greensboro, USA, marks a key milestone in Sanner’s long-term growth strategy,” says Christian Classen, Chief Sales Officer of the Sanner Group. “We are strengthening our position as a trusted CDMO partner—bringing together proven expertise, technological excellence, and a strong track record in drug delivery, diagnostics, and medtech devices. At the same time, we are expanding our active primary healthcare packaging business with local production capabilities in the United States. This enables us to serve our North American customers more efficiently, with shorter delivery times and the consistent, high quality they expect from Sanner.”
Building on a company history that spans more than 130 years, Sanner has continuously evolved into a global provider of plastic healthcare packaging and device-related offerings. With decades of experience in desiccant packaging and moisture management solutions for the healthcare industry, and a steadily expanding portfolio that now includes medical device capabilities, Sanner continues to grow its global footprint and deepen its commitment to the U.S. market, where it has been active since 1995.
About Sanner
Sanner GmbH was founded in 1894. Headquartered in Germany with best-in-class manufacturing facilities across Germany, France, Hungary, China, and the U.S., Sanner has successively developed from a global market leader for desiccant closures and effervescent tablet packaging into a sought-after provider of customized solutions in the areas of medical devices and diagnostics, pharmaceuticals, and consumer healthcare. Today, Sanner supplies its products to more than 150 countries globally and has more than 820 employees. In November 2021, GHO Capital, Europe’s leading specialist investor in healthcare, acquired a majority stake in Sanner to partner with the fourth generation of the Sanner family to continue to support the growth of the company with a specific focus on transforming Sanner into a global MedTech CDMO.
Media contact
Commha Consulting GmbH & Co. KG
Annette Crowther
Tel. +49 6221 18779-27